Regulation of alternative macrophage activation by galectin-3

Journal of Immunology

Volumn 180, Issue 4, 2008, Pages 2650-2658

  MacKinnon, Alison C ^a   Farnworth, Sarah L ^a   Hodkinson, Philip S ^a   Henderson, Neil C ^a   Atkinson, Kirsten M ^a   Leffler, Hakon ^b   Nilsson, Ulf J ^b   Haslett, Christopher ^a   Forbes, Stuart J ^a   Sethi, Tariq ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD98 ANTIGEN; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; GALECTIN 3; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; SMALL INTERFERING RNA; PHOSPHATIDYLINOSITOL 3 KINASE;

AMINO ACID ANALYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTHMA; B LYMPHOCYTE; COMPLEMENT SYSTEM; CROSS LINKING; ENZYME ASSAY; ENZYME INHIBITION; EXOGENOUS VARIABLE; FEEDBACK SYSTEM; FIBROSIS; GENE DISRUPTION; GENE TARGETING; GENETIC TRANSFECTION; GRANULOMATOSIS; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOMODULATION; IMMUNOPRECIPITATION; IN VITRO STUDY; LUNG; LYMPHOCYTE ACTIVATION; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; TISSUE CULTURE; WESTERN BLOTTING; ANIMAL; AUTOCRINE EFFECT; BIOSYNTHESIS; BONE MARROW CELL; COMPARATIVE STUDY; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; LUNG ALVEOLUS MACROPHAGE; METABOLISM; MONOCYTE; MOUSE MUTANT; PERITONEUM MACROPHAGE; PHYSIOLOGY; TUMOR CELL LINE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIGENS, CD98; AUTOCRINE COMMUNICATION; BONE MARROW CELLS; CELL LINE, TUMOR; ENZYME ACTIVATION; FEEDBACK, BIOCHEMICAL; GALECTIN 3; GENE EXPRESSION REGULATION; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MACROPHAGES, ALVEOLAR; MACROPHAGES, PERITONEAL; MICE; MICE, KNOCKOUT; MONOCYTES;

EID: 42149161735     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.4.2650     Document Type: Article

References (62)

1. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3: 23-35.
2. Stout, R. D., C. Jiang, B. Matta, I. Tietzel, S. K. Watkins, and J. Suttles. 2005. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J. Immunol. 175: 342-349.
3. Gordon, S., I. Fraser, D. Nath, D. Hughes, and S. Clarke. 1992. Macrophages in tissues and in vitro. Curr. Opin. Immunol. 4: 25-32.
4. Mantovani, A., S. Sozzani, M. Locati, P. Allavena, and A. Sica. 2002. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23: 549-555.
5. + T cells correlates with Th1/Th2 phenotype. J. Immunol. 160: 5347-5354.
6. Holscher, C., R. A. Atkinson, B. Arendse, N. Brown, E. Myburgh, G. Alber, and F. Brombacher. 2001. A protective and agonistic function of IL-12p40 in mycobacterial infection. J. Immunol. 167: 6957-6966.
7. Louis, J., H. Himmelrich, C. Parra-Lopez, F. Tacchini-Cottier, and P. Launois. 1998. Regulation of protective immunity against Leishmania major in mice. Curr. Opin. Immunol. 10: 459-464.
8. Munder, M., K. Eichmann, J. M. Moran, F. Centeno, G. Soler, and M. Modolell. 1999. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J. Immunol. 163: 3771-3777.
9. Welch, J. S., L. Escoubet-Lozach, D. B. Sykes, K. Liddiard, D. R. Greaves, and C. K. Glass. 2002. TH2 cytokines and allergic challenge induce Ym1 expression in macrophages by a STAT6-dependent mechanism. J. Biol. Chem. 277: 42821-42829.
10. Hesse, M., M. Modolell, A. C. La Flamme, M. Schito, J. M. Fuentes, A. W. Cheever, E. J. Pearce, and T. A. Wynn. 2001. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J. Immunol. 167: 6533-6544.
11. Stein, M., S. Keshav, N. Harris, and S. Gordon. 1992. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176: 287-292.
12. Nair, M. G., I. J. Gallagher, M. D. Taylor, P. Loke, P. S. Coulson, R. A. Wilson, R. M. Maizels, and J. E. Allen. 2005. Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Ym1 and Fizz1 by antigen-presenting cells. Infect. Immun. 73: 385-394.
13. Raes, G., W. Noel, A. Beschin, L. Brys, P. de Baetselier, and G. H. Hassanzadeh. 2002. FIZZ1 and Ym as tools to discriminate between differentially activated macrophages. Dev. Immunol. 9: 151-159.
14. Herbert, D. R., C. Holscher, M. Mohrs, B. Arendse, A. Schwegmann, M. Radwanska, M. Leeto, R. Kirsch, P. Hall, H. Mossmann, et al. 2004. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 20: 623-635.
15. Nair, M. G., D. W. Cochrane, and J. E. Allen. 2003. Macrophages in chronic type 2 inflammation have a novel phenotype characterized by the abundant expression of Ym1 and Fizz1 that can be partly replicated in vitro. Immunol. Lett. 85: 173-180.
16. Nelms, K., A. D. Keegan, J. Zamorano, J. J. Ryan, and W. E. Paul. 1999. The IL-4 receptor: signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17: 701-738.
17. Keegan, A. D., K. Nelms, M. White, L. M. Wang, J. H. Pierce, and W. E. Paul. 1994. An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell 76: 811-820.
18. O'Shea, J. J., M. Gadina, and R. D. Schreiber. 2002. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 109 (Suppl.): S121-S131.
19. Wynn, T. A. 2003. IL-13 effector functions. Annu. Rev. Immunol. 21: 425-456.
20. Raes, G., L. Brys, B. K. Dahal, J. Brandt, J. Grooten, F. Brombacher, G. Vanham, W. Noel, P. Bogaert, T. Boonefaes, et al. 2005. Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation. J. Leukocyte Biol. 77: 321-327.
21. Wynn, T. A. 2004. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat. Rev. Immunol. 4: 583-594.
22. Sica, A., T. Schioppa, A. Mantovani, and P. Allavena. 2006. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur. J. Cancer 42: 717-727.
23. Hughes, R. C. 1997. The galectin family of mammalian carbohydrate-binding molecules. Biochem. Soc. Trans. 25: 1194-1198.
24. Sano, H., D. K. Hsu, L. Yu, J. R. Apgar, I. Kuwabara, T. Yamanaka, M. Hirashima, and F. T. Liu. 2000. Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J. Immunol. 165: 2156-2164.
25. Kuwabara, I., and F. T. Liu. 1996. Galectin-3 promotes adhesion of human neutrophils to laminin. J. Immunol. 156: 3939-3944.
26. Barondes, S. H., D. N. Cooper, M. A. Gitt, and H. Leffler. 1994. Galectins: structure and function of a large family of animal lectins. J. Biol. Chem. 269: 20807-20810.
27. Sharma, U. C., S. Pokharel, T. J. van Brakel, J. H. van Berlo, J. P. Cleutjens, B. Schroen, S. Andre, H. J. Crijns, H. J. Gabius, J. Maessen, and Y. M. Pinto. 2004. Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation 110: 3121-3128.
28. Liu, F. T., D. K. Hsu, R. I. Zuberi, I. Kuwabara, E. Y. Chi, and W. R. Henderson, Jr. 1995. Expression and function of galectin-3, a β-galactoside-binding lectin, in human monocytes and macrophages. Am. J. Pathol. 147: 1016-1028.
29. Dietz, A. B., P. A. Bulur, G. J. Knutson, R. Matasic, and S. Vuk-Pavlovic. 2000. Maturation of human monocyte-derived dendritic cells studied by microarray hybridization. Biochem. Biophys. Res. Commun. 275: 731-738.
30. Helming, L., and S. Gordon. 2007. Macrophage fusion induced by IL-4 alternative activation is a multistage process involving multiple target molecules. Eur. J. Immunol. 37: 33-42.
31. Okamoto, H., K. Mizuno, and T. Horio. 2003. Monocyte-derived multinucleated giant cells and sarcoidosis. J. Dermatol. Sci. 31: 119-128.
32. Henderson, N. C., A. C. Mackinnon, S. L. Farnworth, F. Poirier, F. P. Russo, J. P. Iredale, C. Haslett, K. J. Simpson, and T. Sethi. 2006. Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc. Natl. Acad. Sci. USA 103: 5060-5065.
33. Verrey, F., E. I. Closs, C. A. Wagner, M. Palacin, H. Endou, and Y. Kanai. 2004. CATs and HATs: the SLC7 family of amino acid transporters. Pflügers Arch. 447: 532-542.
34. Dong, S., and R. C. Hughes. 1997. Macrophage surface glycoproteins binding to galectin-3 (Mac-2-antigen). Glycoconj. J. 14: 267-274.
35. Henderson, N. C., E. A. Collis, A. C. Mackinnon, K. J. Simpson, C. Haslett, R. Zent, M. Ginsberg, and T. Sethi. 2004. CD98hc (SLC3A2) interaction with beta 1 integrins is required for transformation. J. Biol. Chem. 279: 54731-54741.
36. Rintoul, R. C., R. C. Buttery, A. C. Mackinnon, W. S. Wong, D. Mosher, C. Haslett, and T. Sethi. 2002. Cross-linking CD98 promotes integrin-like signaling and anchorage-independent growth. Mol. Biol. Cell 13: 2841-2852.
37. Cumpstey, I., A. Sundin, H. Leffler, and U. J. Nilsson. 2005. C2-symmetrical thiodigalactoside bis-benzamido derivatives as high-affinity inhibitors of galectin-3: efficient lectin inhibition through double arginine-arene interactions. Angew. Chem. Int. Ed. Engl. 44: 5110-5112.
38. Colnot, C., M. A. Ripoche, G. Milon, X. Montagutelli, P. R. Crocker, and F. Poirier. 1998. Maintenance of granulocyte numbers during acute peritonitis is defective in galectin-3-null mutant mice. Immunology 94: 290-296.
39. Duffield, J. S., S. J. Forbes, C. M. Constandinou, S. Clay, M. Partolina, S. Vuthoori, S. Wu, R. Lang, and J. P. Iredale. 2005. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 115: 56-65.
40. Hart, S. P., G. J. Dougherty, C. Haslett, and I. Dransfield. 1997. CD44 regulates phagocytosis of apoptotic neutrophil granulocytes, but not apoptotic lymphocytes, by human macrophages. J. Immunol. 159: 919-925.
41. Corraliza, I. M., M. L. Campo, G. Soler, and M. Modolell. 1994. Determination of arginase activity in macrophages: a micromethod. J. Immunol. Methods 174: 231-235.
42. 2+ in human Jurkat T-cells. FEBS Lett. 395: 165-169.
43. Cho, J. Y., A. R. Kim, H. G. Joo, B. H. Kim, M. H. Rhee, E. S. Yoo, D. R. Katz, B. M. Chain, and J. H. Jung. 2004. Cynaropicrin, a sesquiterpene lactone, as a new strong regulator of CD29 and CD98 functions. Biochem. Biophys. Res. Commun. 313: 954-961.
44. Dumic, J., S. Dabelic, and M. Flogel. 2006. Galectin-3: an open-ended story. Biochim. Biophys. Acta 1760: 616-635.
45. Partridge, E. A., C. Le Roy, G. M. Di Guglielmo, J. Pawling, P. Cheung, M. Granovsky, I. R. Nabi, J. L. Wrana, and J. W. Dennis. 2004. Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science 306: 120-124.
46. Shimura, T., Y. Takenaka, S. Tsutsumi, V. Hogan, A. Kikuchi, and A. Raz. 2004. Galectin-3, a novel binding partner of β-catenin. Cancer Res. 64: 6363-6367.
47. Sato, S., and R. C. Hughes. 1994. Regulation of secretion and surface expression of Mac-2, a galactoside-binding protein of macrophages. J. Biol. Chem. 269: 4424-4430.
48. Diaz-Guerra, M. J., A. Castrillo, P. Martin-Sanz, and L. Bosca. 1999. Negative regulation by phosphatidylinositol 3-kinase of inducible nitric oxide synthase expression in macrophages. J. Immunol. 162: 6184-6190.
49. Schabbauer, G., M. Tencati, B. Pedersen, R. Pawlinski, and N. Mackman. 2004. PI3K-Akt pathway suppresses coagulation and inflammation in endotoxemic mice. Arterioscler. Thromb. Vasc. Biol. 24: 1963-1969.
50. Rauh, M. J., V. Ho, C. Pereira, A. Sham, L. M. Sly, V. Lam, L. Huxham, A. I. Minchinton, A. Mui, and G. Krystal. 2005. SHIP represses the generation of alternatively activated macrophages. Immunity 23: 361-374.
51. McNally, A. K., and J. M. Anderson. 2002. β1 and β2 integrins mediate adhesion during macrophage fusion and multinucleated foreign body giant cell formation. Am. J. Pathol. 160: 621-630.
52. Tajima, M., S. Higuchi, Y. Higuchi, N. Miyamoto, A. Uchida, M. Ito, M. Nishio, H. Komada, M. Kawano, S. Kusagawa, et al. 1999. Suppression of FRP-1/CD98-mediated multinucleated giant cell and osteoclast formation by an anti-FRP-1/CD98 mAb, HBJ 127, that inhibits c-src expression. Cell. Immunol. 193: 162-169.
53. Nagaoka, T., Y. Kaburagi, Y. Hamaguchi, M. Hasegawa, K. Takehara, D. A. Steeber, T. F. Tedder, and S. Sato. 2000. Delayed wound healing in the absence of intercellular adhesion molecule-1 or L-selectin expression. Am. J. Pathol. 157: 237-247.
54. Teder, P., R. W. Vandivier, D. Jiang, J. Liang, L. Cohn, E. Pure, P. M. Henson, and P. W. Noble. 2002. Resolution of lung inflammation by CD44. Science 296: 155-158.
55. Endo, M., S. Oyadomari, Y. Terasaki, M. Takeya, M. Suga, M. Mori, and T. Gotoh. 2003. Induction of arginase I and II in bleomycin-induced fibrosis of mouse lung. Am. J. Physiol. 285: L313-L321.
56. Grasemann, H., R. Schwiertz, S. Matthiesen, K. Racke, and F. Ratjen. 2005. Increased arginase activity in cystic fibrosis airways. Am. J. Respir. Crit. Care Med. 172: 1523-1528.
57. Fichtner-Feigl, S., W. Strober, K. Kawakami, R. K. Puri, and A. Kitani. 2006. IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-β1 production and fibrosis. Nat. Med. 12: 99-106.
58. Liu, T., H. Jin, M. Ullenbruch, B. Hu, N. Hashimoto, B. Moore, A. McKenzie, N. W. Lukacs, and S. H. Phan. 2004. Regulation of found in inflammatory zone 1 expression in bleomycin-induced lung fibrosis: role of IL-4/IL-13 and mediation via STAT-6. J. Immunol. 173: 3425-3431.
59. Doucet, C., D. Brouty-Boye, C. Pottin-Clemenceau, C. Jasmin, G. W. Canonica, and B. Azzarone. 1998. IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts. Int. Immunol. 10: 1421-1433.
60. Rishikof, D. C., D. A. Ricupero, P. P. Kuang, H. Liu, and R. H. Goldstein. 2002. Interleukin-4 regulates connective tissue growth factor expression in human lung fibroblasts. J. Cell. Biochem. 85: 496-504.
61. Pugliese, G., F. Pricci, C. Iacobini, G. Leto, L. Amadio, P. Barsotti, L. Frigeri, D. K. Hsu, H. Vlassara, F. T. Liu, and U. Di Mario. 2001. Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice. FASEB J. 15: 2471-2479.
62. Lopez, E., V. del Pozo, T. Miguel, B. Sastre, C. Seoane, E. Civantos, E. Llanes, M. L. Baeza, P. Palomino, B. Cardaba, et al. 2006. Inhibition of chronic airway inflammation and remodeling by galectin-3 gene therapy in a murine model. J. Immunol. 176: 1943-1950.